Trials / Completed
CompletedNCT00828438
Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment
A Phase 1, Open-Label, Single-Dose Study of the Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the PK properties of lorcaserin in subjects with end stage renal disease (ESRD) who require dialysis and will be studied under dialysis and non-dialysis conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lorcaserin 10mg |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2009-01-26
- Last updated
- 2019-09-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00828438. Inclusion in this directory is not an endorsement.